List of Tables

Table 1. Injection Peptide Drug Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Injection Peptide Drug Market Restraints

Table 3. Injection Peptide Drug Market Trends

Table 4. Injection Peptide Drug Industry Policy

Table 5. Global Injection Peptide Drug Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Injection Peptide Drug Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Injection Peptide Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Injection Peptide Drug Mergers & Acquisitions, Expansion Plans

Table 9. Global Injection Peptide Drug Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Injection Peptide Drug Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 12. China Injection Peptide Drug Revenue Market Share by Company, 2020-2025

Table 13. Global Key Players of Injection Peptide Drug Upstream (Raw Materials)

Table 14. Global Injection Peptide Drug Typical Customers

Table 15. Injection Peptide Drug Typical Distributors

Table 16. by Type, Global Injection Peptide Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 17. by Application, Global Injection Peptide Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 18. By Region, Global Injection Peptide Drug Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 19. By Region, Global Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Table 20. By Country, Global Injection Peptide Drug Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 21. By Country, Global Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Table 22. By Country, Global Injection Peptide Drug Consumption Value Market Share, 2020-2031

Table 23. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 24. Sanofi Company Profile and Main Business

Table 25. Sanofi Injection Peptide Drug Models, Specifications, and Application

Table 26. Sanofi Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 27. Sanofi Recent Developments

Table 28. Teva Company Information, Head Office, Market Area, and Industry Position

Table 29. Teva Company Profile and Main Business

Table 30. Teva Injection Peptide Drug Models, Specifications, and Application

Table 31. Teva Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 32. Teva Recent Developments

Table 33. Novo Nordisk Company Information, Head Office, Market Area, and Industry Position

Table 34. Novo Nordisk Company Profile and Main Business

Table 35. Novo Nordisk Injection Peptide Drug Models, Specifications, and Application

Table 36. Novo Nordisk Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 37. Novo Nordisk Recent Developments

Table 38. Takeda Company Information, Head Office, Market Area, and Industry Position

Table 39. Takeda Company Profile and Main Business

Table 40. Takeda Injection Peptide Drug Models, Specifications, and Application

Table 41. Takeda Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 42. Takeda Recent Developments

Table 43. Eli Lilly Company Information, Head Office, Market Area, and Industry Position

Table 44. Eli Lilly Company Profile and Main Business

Table 45. Eli Lilly Injection Peptide Drug Models, Specifications, and Application

Table 46. Eli Lilly Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 47. Eli Lilly Recent Developments

Table 48. AstraZeneca Company Information, Head Office, Market Area, and Industry Position

Table 49. AstraZeneca Company Profile and Main Business

Table 50. AstraZeneca Injection Peptide Drug Models, Specifications, and Application

Table 51. AstraZeneca Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 52. AstraZeneca Recent Developments

Table 53. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 54. Novartis Company Profile and Main Business

Table 55. Novartis Injection Peptide Drug Models, Specifications, and Application

Table 56. Novartis Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 57. Novartis Recent Developments

Table 58. AbbVie Company Information, Head Office, Market Area, and Industry Position

Table 59. AbbVie Company Profile and Main Business

Table 60. AbbVie Injection Peptide Drug Models, Specifications, and Application

Table 61. AbbVie Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 62. AbbVie Recent Developments

Table 63. Ipsen Company Information, Head Office, Market Area, and Industry Position

Table 64. Ipsen Company Profile and Main Business

Table 65. Ipsen Injection Peptide Drug Models, Specifications, and Application

Table 66. Ipsen Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 67. Ipsen Recent Developments

Table 68. Ferring Company Information, Head Office, Market Area, and Industry Position

Table 69. Ferring Company Profile and Main Business

Table 70. Ferring Injection Peptide Drug Models, Specifications, and Application

Table 71. Ferring Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 72. Ferring Recent Developments

Table 73. Merck Company Information, Head Office, Market Area, and Industry Position

Table 74. Merck Company Profile and Main Business

Table 75. Merck Injection Peptide Drug Models, Specifications, and Application

Table 76. Merck Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 77. Merck Recent Developments

Table 78. The Medicines Company Information, Head Office, Market Area, and Industry Position

Table 79. The Medicines Company Profile and Main Business

Table 80. The Medicines Injection Peptide Drug Models, Specifications, and Application

Table 81. The Medicines Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 82. The Medicines Recent Developments

Table 83. J & J Company Information, Head Office, Market Area, and Industry Position

Table 84. J & J Company Profile and Main Business

Table 85. J & J Injection Peptide Drug Models, Specifications, and Application

Table 86. J & J Injection Peptide Drug Revenue and Gross Margin, US$ Million, 2020-2025

Table 87. J & J Recent Developments

List of Figures

Figure 1. Injection Peptide Drug Picture

Figure 2. Global Injection Peptide Drug Consumption Value, (US$ million) & (2020-2031)

Figure 3. China Injection Peptide Drug Consumption Value, (US$ million) & (2020-2031)

Figure 4. By Consumption Value, China Injection Peptide Drug Market Share of Global, 2020-2031

Figure 5. Global Injection Peptide Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 6. China Injection Peptide Drug Key Participants, Market Share, 2024

Figure 7. Injection Peptide Drug Industry Chain

Figure 8. Injection Peptide Drug Procurement Model

Figure 9. Injection Peptide Drug Sales Model

Figure 10. Injection Peptide Drug Sales Channels, Direct Sales, and Distribution

Figure 11. Intravenous Injection

Figure 12. Subcutaneous Injection

Figure 13. by Type, Global Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Figure 14. by Type, Global Injection Peptide Drug Consumption Value Market Share, 2020-2031

Figure 15. Cancer

Figure 16. Metabolic Disorders

Figure 17. Central Nervous System

Figure 18. Other

Figure 19. by Application, Global Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Figure 20. by Application, Global Injection Peptide Drug Revenue Market Share, 2020-2031

Figure 21. By Region, Global Injection Peptide Drug Consumption Value Market Share, 2020-2031

Figure 22. North America Injection Peptide Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 23. By Country, North America Injection Peptide Drug Consumption Value Market Share, 2024

Figure 24. Europe Injection Peptide Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 25. By Country, Europe Injection Peptide Drug Consumption Value Market Share, 2024

Figure 26. Asia Pacific Injection Peptide Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 27. By Country/Region, Asia Pacific Injection Peptide Drug Consumption Value Market Share, 2024

Figure 28. South America Injection Peptide Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 29. By Country, South America Injection Peptide Drug Consumption Value Market Share, 2024

Figure 30. Middle East & Africa Injection Peptide Drug Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 31. United States Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Figure 32. by Type, United States Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 33. by Application, United States Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 34. Europe Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Figure 35. by Type, Europe Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 36. by Application, Europe Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 37. China Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Figure 38. by Type, China Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 39. by Application, China Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 40. Japan Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Figure 41. by Type, Japan Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 42. by Application, Japan Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 43. South Korea Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Figure 44. by Type, South Korea Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 45. by Application, South Korea Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 46. Southeast Asia Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Figure 47. by Type, Southeast Asia Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 48. by Application, Southeast Asia Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 49. India Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Figure 50. by Type, India Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 51. by Application, India Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 52. Middle East & Africa Injection Peptide Drug Consumption Value, 2020-2031, US$ Million

Figure 53. by Type, Middle East & Africa Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 54. by Application, Middle East & Africa Injection Peptide Drug Consumption Value Market Share, 2024 VS 2031

Figure 55. Research Methodology

Figure 56. Breakdown of Primary Interviews

Figure 57. Bottom-up Approaches

Figure 58. Top-down Approaches